Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli.
Open Access
- 1 August 1990
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 86 (2) , 631-641
- https://doi.org/10.1172/jci114755
Abstract
Escherichia coli ingested by PMN promptly stop growing and form no colonies in nutrient agar, but metabolize near normally for up to several hours. The bactericidal/permeability increasing protein (BPI) of PMN also inhibits E. coli growth without initial metabolic impairment. We recently showed that BPI-treated E. coli, although unable to grow in normal nutrient agar, can form colonies in this medium plus 0.1% BSA, as long as their metabolism is maintained, indicating that biochemical impairment is a better indicator of death than growth arrest (1990. J. Clin. Invest. 85:853-860). We have now reexamined the fate of ingested E. coli. Rabbit PMN ingest greater than 85% of several rough E. coli strains in 15 min, but greater than 80% of these bacteria, while unable to form colonies in conventional agar, grow normally on agar plus 0.1% BSA. Thus, the PMN under these conditions promptly stop growth of ingested E. coli without killing. Adding nonlethal concentrations of normal human serum (NHS) before, but not after ingestion, accelerates killing and, in parallel, loss of bacterial metabolism (t1/2 less than 0.5 h vs. greater than 3 h, respectively, with and without NHS). The rapid killing of both rough and smooth E. coli pretreated with NHS is lost after C7 depletion (C7-D) and restored when C7 is replenished. Similar results are obtained with human PMN. In contrast, ingested Staphylococcus epidermidis, opsonized with either NHS or C7-D serum rapidly stop metabolizing and do not form colonies in nutrient agar with or without BSA. Respiratory burst activity is the same during ingestion of E. coli (with or without NHS) and S. epidermidis. Killing of E. coli J5 (however, not of O111-B4) by BPI is also accelerated by pretreatment with NHS but not C7-D human serum. These findings indicate that late complement components are needed for efficient killing of both rough and smooth E. coli by PMN, and that BPI is the principal intracellular agent acting on ingested rough E. coli.This publication has 28 references indexed in Scilit:
- Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases.Journal of Clinical Investigation, 1990
- Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.The Journal of Immunology, 1989
- Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes.Journal of Clinical Investigation, 1985
- Moculating effect of the late-acting components of the complement system on the bactericidal activity of human polymorphonuclear leukocytes on E. coli 0111:B4.The Journal of Immunology, 1981
- Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes.Journal of Biological Chemistry, 1978
- The effects of the morphine analogue levorphanol on leukocytesJournal of Clinical Investigation, 1971
- Uptake of fat by phagocytic cells. An examination of the role of phagocytosisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1965
- INHIBITION OF RNA SYNTHESIS IN FSCHERICHIA COLI BY LEVORPHANOLProceedings of the National Academy of Sciences, 1964
- The Biochemical Basis of PhagocytosisJournal of Biological Chemistry, 1959
- STUDIES ON THE SODIUM AND POTASSIUM TRANSPORT IN RABBIT POLYMORPHONUCLEAR LEUKOCYTESThe Journal of general physiology, 1959